Every detail counts when participating in clinical trials, according to one panelist at the virtual Women in Ophthalmology Summer Symposium.
Key areas that deserve scrupulous attention are obtaining consent, adhering to inclusion/exclusion criteria, appropriately randomizing patients, and correct drug distribution and documentation, Penny A. Asbell, MD, FACS, MBA, FARVO, said in the WIO’s inaugural clinical trials training program session.
“Those are things that come up in every trial, and you cannot screw them up,” Asbell said.
The institutional review board, the FDA, the
Uncategorized